Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease

Corey A. Siegel, L. Campbell Levy, Todd A. MacKenzie, Bruce E. Sands

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease'. Together they form a unique fingerprint.

Medicine & Life Sciences